Abstract | BACKGROUND: METHODS: A total of 119 patients (139 lesions) with HCC who were treated with SBRT were registered between March 2012 and July 2013 at our institution. A dose of 10-15 Gy per fraction was applied over 3-4 consecutive days, resulting in a total dose of 30-60 Gy. RESULTS: The median follow-up period was 25.8 months (range, 3.2-36.8 months). The overall 3-year survival rate was 83.8%. The local control rate at 3 years was 97.0% in all treated lesions. Multivariate analysis revealed that the Child-Pugh class before SBRT had significant effects on overall survival (Child-Pugh A: hazard ratio = 0.463; 95% CI, 0.262-0.817; p = 0.008). CONCLUSIONS: SBRT using a respiratory-gated VMAT technique was an excellent ablative treatment modality for patients with HCC. SBRT is a good alternative treatment for patients with small HCCs that are unsuitable for surgical resection or local ablative therapy.
|
Authors | Yuri Jeong, Jinhong Jung, Byungchul Cho, Jungwon Kwak, Chiyoung Jeong, Jong Hoon Kim, Jin-Hong Park, So Yeon Kim, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sang Min Yoon |
Journal | BMC cancer
(BMC Cancer)
Vol. 18
Issue 1
Pg. 416
(04 13 2018)
ISSN: 1471-2407 [Electronic] England |
PMID | 29653562
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular
(diagnostic imaging, pathology, radiotherapy)
- Female
- Follow-Up Studies
- Humans
- Liver Neoplasms
(diagnostic imaging, pathology, radiotherapy)
- Male
- Middle Aged
- Neoplasm Staging
- Radiosurgery
(adverse effects, methods)
- Radiotherapy, Intensity-Modulated
(adverse effects, methods)
- Retrospective Studies
- Tomography, X-Ray Computed
- Treatment Outcome
- Tumor Burden
|